 |
Kevin M. Moerman is a computational mechanics and computational design expert. His research interests include computational geometry and design, design optimisation, finite element analysis (FEA), continuum mechanics, meshing, signal and image-processing, robotics and mechatronics, medical device design, additive manufacturing, generative design and morphogenesis. After obtaining a Bachelor degree in Mechanical Engineering (2004, The Hague University of Applied Sciences) he worked in the industry as a robotics design engineer. In 2005 he completed a Master’s degree in Bioengineering at Trinity College Dublin, where he subsequently pursued a PhD degree on the topic of inverse FEA to study soft tissue biomechanics (2012). He received several awards for both his undergraduate and PhD research. Following his PhD Kevin was a postdoctoral researcher at the Academical Medical Centre in Amsterdam, where he developed computational and experimental methods for non-invasive pressure ulcer analysis and detection. In 2015 Kevin joined the MIT Media Lab’s Biomechatronics group, where he became a Research Scientist (2017) to lead the group's Computational Biomechanics research track an co-supervise (under)graduate students. His research at MIT focused on computational methods for automated subject-specific prosthetic socket design and design optimisation. These methods were combined with advanced multi-material 3D printing techniques to achieve spatially varying compliance. He also co-authored several grants leading to the group receiving an NIH R01 to further research on prosthetic device design. In 2018 Kevin returned to Ireland. He is now a Research Fellow at NUI Galway, where his research involves the development of constitutive formulations of blood clots, and computational modelling of blood clot occlusion during stroke. During his academic career Kevin has developed a vast array of tools for computational mechanics, finite element analysis, computational design, meshing, and image and signal processing, which has resulted in the creation of the GIBBON open-source software project. GIBBON is now used worldwide for computational (bio)mechanics, and is often the source of international collaborations. Kevin has shared his work at international conferences and has chaired and organized many special sessions and workshops. His multidisciplinary nature and ability to collaborate is clear from his publication record which demonstrates works on inverse FEA, continuum mechanics, instrument design, MRI methods, and software development. Furthermore he holds several patents in (agricultural) robotics and (prosthetic) device design. Besides his academic reputation, Kevin is also a well known advocate for open science and open source software. He is a co-founder and editor for the Journal of Open Source Software, and an editor for the Journal of Open Hardware and the Journal of Open Engineering. He was also involved in the creation of the Engineering Archive (the now well-established pre-print server for Engineering) and is a member of its steering committee. In 2016 he hosted and organized an IEEE Boston Chapter course open “Open Source Tools for Computational Biomechanics”, and in 2017 he hosted and organized the Boston “Working Open Workshop” together with the Mozilla Science Lab, to teach fellow researchers about the principles of open science. Kevin currently lives in Galway, Ireland, with his wife and two sons. |
 |
Prof. Yvo Roos, MD is Professor of Acute Neurology and head of department in the Amsterdam UMC, location AMC, Amsterdam, The Netherlands. As a AMC principle investigator (PI) he has been focusing his research on the acute treatment of stroke patients. As such, he has set-up and published over the years several large clinical trials on patients with Aneurysmal Subarachnoid Hemorrhage and Intracerebral hemorrhages (Lancet). The last decade his main focus, however, was on the acute treatment of patients with an ischemic stroke. He initiated a dedicated Acute Brain Care Unit at the emergency department to improve so called door-to-needle times of patients treated with intravenous thrombolysis (Time is Brain principle). This ultra-early treatment system formed the basis for the endovascular treatment setup in the Academic Medical Center Amsterdam. This treatment protocol also served as the blueprint for the treatment arm of MRCLEAN trial. This trial, published in the NEJM, showed for the first time that outcome of patients with severe ischemic stroke could be improved significantly when the clot is removed directly form the occluded artery through a catheter. The trial was awarded with several prizes including the 2017 Science and Innovation Award of the Dutch Federation of Medical Specialists. The MRCLEAN trial results are internationally shared within pooled analyses in two projects – as such Yvo is member of the HERMES and the VISTA projects. He is currently one of the executive members of the MRCLEAN Registry study, a population-level real world experience and exemplary for medical registries globally. All patients with acute ischemic stroke who undergo treatment with the catheter in the Netherlands are registered, currently over 4500 patients. Results of the Registry are published and show that endovascular treatment of acute ischemic stroke is at least as effective as shown in the clinical trial. After the MRCLEAN trial Yvo initiated and was PI of the CLOT-MRCLEAN study, also published in the NEJM. This study showed that the effects of treatment are sustainable over time. It also shows that this treatment is highly cost-effective (not yet published results), which is very important to facilitate the implementation of this new treatment modality all over the world. Currently he is co-PI of the new MRCLEAN No-IV trial within the CONTRAST-consortium (www.contrast-consortium.nl). And he is also on the steering committee of the DIRECT-MT trial which is now enrolling patients in 40 hospitals in China, a study similar to the MRCLEAN No-IV. Yvo has (co)authored more than 200 peer-reviewed manuscript and has a Hirsch index of 42 (Google Scholar). |
|
Prof. de Meyer Name: De Meyer Simon F., born 08/04/1977 (Roeselare, Belgium) University degrees: - Industrial Engineer in Biochemistry (KHBO, Ostend, Belgium): magna cum laude,1999
Academic appointments:
Prizes/Awards (More than 15 travel grants/awards, not listed)
Other
Three recent key publications
|
 |
José Félix Rodríguez Matas was born in Cardón (Venezuela) in 1971. He received the B.E. degree in mechanical engineering from Universidad Simón Bolívar, Carcas (Venezuela) in 1993,and the Ph.D. degree in mechanical engineering from the University of Notre Dame (USA) in 1999. He was associated professor at Universidad Simón Bolívar from 2001 to 2004. In 2004 he moved to the Mechanical Engineering Department at Universidad de Zaragoza, Zaragoza (Spain) as a Ramón y Cajal fellow, becoming associate professor in 2011. In 2015 he moved to the Department of Chemistry, Materials and Chemical Engineering “Giulio Natta” at Politecnico di Milano where he is currently associate professor. His research interests concern numerical methods, the biomechanics of soft tissues, vascular biomechanics, and cardiac electrophysiology. He is particularly involved in the material modelling of soft tissues and nonlinear finite element applications, as well as the development of efficient computational tools for cardiac electrophysiology. He serves as reviewer for a number of peer-review international journals. He is a member of European Society of Biomechanics (ESB) and has co-authored more than 50 peer-reviewed international journals. Keywords: continuum mechanics – soft tissues – fine element method |
© 2020 FavThemes